T

Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867

Watchlist Manager
Tonghua Dongbao Pharmaceutical Co Ltd
SSE:600867
Watchlist
Price: 8.19 CNY 0.12% Market Closed
Market Cap: 16B CNY
Have any thoughts about
Tonghua Dongbao Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Tonghua Dongbao Pharmaceutical Co Ltd

Current Assets 2B
Cash & Short-Term Investments 512.4m
Receivables 652.6m
Other Current Assets 864.1m
Non-Current Assets 5B
Long-Term Investments 654.6m
PP&E 2.7B
Intangibles 1.4B
Other Non-Current Assets 256.7m
Current Liabilities 406.8m
Accounts Payable 132.7m
Accrued Liabilities 4m
Short-Term Debt 251.5m
Other Current Liabilities 18.6m
Non-Current Liabilities 146.5m
Long-Term Debt 107.5m
Other Non-Current Liabilities 39m

Balance Sheet
Tonghua Dongbao Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
202
212
236
336
356
297
593
865
788
1 104
Cash
0
0
0
0
0
0
0
865
788
1 104
Cash Equivalents
202
212
236
336
356
297
593
0
0
0
Short-Term Investments
0
0
0
0
0
203
150
37
58
56
Total Receivables
431
427
483
569
665
699
596
673
511
917
Accounts Receivables
392
385
450
544
558
552
510
559
422
793
Other Receivables
38
42
33
25
107
147
86
113
88
124
Inventory
630
955
1 048
974
901
629
538
538
654
705
Other Current Assets
50
40
443
361
351
99
45
50
45
34
Total Current Assets
1 312
1 634
2 210
2 240
2 273
1 927
1 922
2 162
2 056
2 816
PP&E Net
1 280
1 813
1 888
1 912
2 056
2 164
2 384
2 603
2 745
2 704
PP&E Gross
1 280
1 813
1 888
1 912
2 056
2 164
2 384
2 603
2 745
2 704
Accumulated Depreciation
903
1 014
1 135
1 265
1 381
1 503
1 613
1 484
1 596
1 695
Intangible Assets
82
102
199
194
389
473
609
797
1 069
1 338
Long-Term Investments
243
193
333
368
385
429
528
557
458
534
Other Long-Term Assets
39
47
45
40
361
358
360
402
422
378
Total Assets
2 956
N/A
3 788
+28%
4 675
+23%
4 753
+2%
5 463
+15%
5 350
-2%
5 803
+8%
6 520
+12%
6 750
+4%
7 771
+15%
Liabilities
Accounts Payable
52
53
91
61
132
69
68
75
81
116
Accrued Liabilities
14
16
18
19
23
19
16
32
12
31
Short-Term Debt
310
873
410
0
450
125
0
0
0
150
Current Portion of Long-Term Debt
0
0
20
0
0
0
0
0
0
0
Other Current Liabilities
85
85
100
95
87
92
124
162
70
223
Total Current Liabilities
461
1 027
639
175
691
305
208
269
162
520
Long-Term Debt
298
250
60
0
0
0
0
0
0
0
Deferred Income Tax
3
0
0
0
0
0
0
0
8
7
Minority Interest
23
20
6
10
10
8
6
5
5
5
Other Liabilities
34
32
31
40
38
36
36
31
31
28
Total Liabilities
819
N/A
1 329
+62%
736
-45%
225
-69%
739
+229%
350
-53%
249
-29%
305
+22%
206
-32%
560
+172%
Equity
Common Stock
1 030
1 136
1 422
1 711
2 034
2 034
2 034
2 034
1 994
1 994
Retained Earnings
960
1 144
1 331
1 599
1 753
2 157
2 679
3 567
4 053
4 725
Additional Paid In Capital
158
208
1 202
1 215
933
935
1 034
1 006
642
623
Treasury Stock
29
29
17
0
0
134
201
398
150
135
Other Equity
19
0
1
3
5
8
8
7
6
5
Total Equity
2 138
N/A
2 459
+15%
3 939
+60%
4 528
+15%
4 724
+4%
5 000
+6%
5 554
+11%
6 215
+12%
6 544
+5%
7 211
+10%
Total Liabilities & Equity
2 956
N/A
3 788
+28%
4 675
+23%
4 753
+2%
5 463
+15%
5 350
-2%
5 803
+8%
6 520
+12%
6 750
+4%
7 771
+15%
Shares Outstanding
Common Shares Outstanding
1 958
1 963
2 048
2 054
2 034
2 023
2 018
2 008
1 991
1 992

See Also

Discover More